Alexandre Fontayne is an R&D expert with over 20 years of experience in the pharmaceutical industry. Author of 28 scientific publications and inventor on 12 patents, he has led multidisciplinary teams in drug design and molecular engineering. Former CEO of Biothelis and Head of the Biotherapeutics Unit at LFB Biotechnologies, he now advises companies on R&D strategy and business development. Passionate about innovation and project management, he supports companies in their preclinical activities and the development of new therapeutic technologies.

• Bioproduction
• CMC ; Antibodies
• Antibody engineering
• Analytical development
• Project management